Mandate

Vinge has advised Oxx in connection with the establishment of Oxx II

December 07, 2023 Private Funds

Oxx closes its second fund generation with USD 190 million in commitments from an international investor base, and thereby increases the fund size by 40% since its latest fund announcement.

Oxx was founded in 2017 and primarily invests in European companies within the B2B SaaS scale-up space.
Vinge’s team primarily consisted of Mattias Schömer, Jesper Ottergren, Viveka Classon, Martin Cronsioe, Semir Omerbasic and Viktoria Wnuk.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025